Pfizer Inc Stock in the Strategy Check

3.6

Low MatchStockScorer score

Compared with its sector, strongest in Momentum and weakest in Growth.

Sector profile

Sector rank: 50.7 of 100
Average of the axes, measured against the large and mid caps of the sector in developed markets. 100 means ahead of that peer group in every area.

18Strategies checked

How does Pfizer Inc stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

Piotroski F-Score (9-Point Check)Nine hard balance-sheet criteria separate substance from a downward spiral.
Low
Mohanram G-Score: Growth QualityFor growth stocks, the substance check shows what is real investment and what is only an announcement.
Low
Defensive: Low VolatilityLow swings instead of maximum return, which is what the low-volatility anomaly exploits.
Medium
StockScorer ScoreMeasured against its own sector: quality, valuation, growth and market confirmation.
Low
Altman Z-Score: Stress TestFive balance-sheet ratios are condensed into a single measure of bankruptcy risk.
High
Dividend Quality: 4 FactorsFour factors against the dividend trap: continuity, coverage, yield, growth.
Medium

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

Open complete overview

Pfizer Inc key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for Pfizer Inc.

P/E ratio21.0

P/B ratio1.9

Return on equity (ROE)9.0 %

Equity ratio41.5 %

Debt-to-equity (D/E)0.78

Dividend yield6.0 %

Unlock further metrics

Unlock for free →

Peer comparison

Put the company in its peer context

Compare the displayed overall score with the unlocked peer rows on this page.

Bounded preview

Comparison view

Pfizer Inc3.6

Peer median6.4

Based on 3 unlocked peers from this page, not on the entire sector.

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

Symbol	Company	Rating
PFE	Pfizer Incthis page
LLY	Eli Lilly and Company	Medium6.4
JNJ	Johnson & Johnson	Medium6.4
LLY.TO	Eli Lilly CDR (CAD Hedged)	Medium6.4
ABBV	AbbVie Inc	locked
MRK	Merck & Company Inc	locked

Unlock the full peer comparison →

Pfizer Inc stock at a glance

Pfizer Inc stock (PFE) is evaluated entirely rule-based in the StockScorer model. It currently reaches a StockScorer score of 3.6 out of 10, which corresponds to a low match with the underlying strategies. The classification is deliberately neutral and is not a recommendation to buy, hold or sell.

Valuation metrics decide the outcome for this stock: P/E, P/B and other multiples, each relative to the sector. Asset value, quality, growth and dividends come in through the other 18 strategies.

Sector classification: Healthcare

Pfizer Inc is assigned to the Healthcare sector. The sector classification makes it possible to compare the stock with peers from the same sector, for example in the peer comparison further up this page.

Frequently asked questions about Pfizer Inc stock

How does Pfizer Inc stock (PFE) score in the StockScorer model?

Pfizer Inc stock reaches a StockScorer score of 3.6 out of 10, which is a low match with the rule-based strategies. It fits the Valuation category best. All values are purely rule-based and updated every business day.

What is Pfizer Inc's P/E ratio?

Pfizer Inc stock currently has a P/E ratio of 21.0, a P/B ratio of 1.9, an equity ratio of 41.5 % and a return on equity (ROE) of 9.0 %.

What sector is Pfizer Inc in?

Pfizer Inc is assigned to the Healthcare sector. StockScorer uses the sector classification, among other things, to relate the stock to comparable peers from the same sector.

Keep exploring

Unlock the full analysis for free

Signed up in 30 seconds. Free, cancel anytime.

✓ More metrics: margin, debt, cash flow and more
✓ Full peer comparison within the same sector
✓ See the match across all strategies in detail
✓ Apply your own scoring profile to any stock
✓ Add the stock to your watchlist and track score changes
✓ Daily updated ratings for 500+ stocks

Start for free →Already registered? Log in now

Not investment advice. The match shown reflects rule-based criteria and is not a recommendation to buy, hold or sell. Further metrics are available after a free sign-up.

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.